Aug 11 (Reuters) - Novogen Ltd NRT.AX
* Novogen submits Investigational New Drug (IND) Application to the U.S. FDA for Cantrixil(TM) in ovarian cancer
* Expect to initiate Cantrixil IND study in last quarter of 2016 Source text for Eikon: ID:nPn5XmbhBa Further company coverage: NRT.AX